Martin MacKay

Martin MacKay

Founder presso RALLYBIO CORPORATION

Patrimonio netto: 5 M $ in data 29/02/2024

68 anni
Commercial Services
Health Technology
Technology Services

Profilo

Martin W.
MacKay
is an American businessperson who founded Rallybio Corp.
and Rallybio LLC and who has been the head of 8 different companies.
Presently, Dr. MacKay is Executive Chairman for Rallybio Corp., Chairman & Chief Executive Officer for Rallybio LLC and Chief Executive Officer & Director at Rallybio Holdings LLC (both are subsidiaries of Rallybio Corp.) and Chief Executive Officer of Calyx Group Ltd.
(Ireland).
He is also on the board of Charles River Laboratories International, Inc., Charles River Laboratories, Inc. and Novo Nordisk A.
In his past career Dr. MacKay held the position of Chief Executive Officer & Director at Neverfail, Inc. and Chief Executive Officer & Director at Neverfail Ltd.
(a subsidiary of Neverfail, Inc.), Senior Vice President-Worldwide Development at Pfizer Inc. and President at Pfizer (St. Louis) (a subsidiary of Pfizer Inc.), President-Research & Development at AstraZeneca PLC and Global Head-Research & Development at Alexion Pharmaceuticals, Inc. (a subsidiary of AstraZeneca PLC), Vice President-International at VeriSign, Inc., Principal at PeopleSoft USA, Inc., Principal at Beecham Pharmaceuticals (UK), Senior Advisor at New Leaf Venture Partners LLC, Chief Executive Officer for Vecta Software Corp.
Ltd., Operations Director for The Dun & Bradstreet Corp., Head-Drug Preformulation & Delivery at BASF Performance Products Ltd.
(United Kingdom), Head-Molecular & Cell Biology at CRI Worldwide LLC, Principal at Accenture LLC, Director-Business Development at NorthgateArinso, Inc. and Head-Drug Preformulation & Delivery at Ciba-Geigy Pharmaceuticals.
He received an undergraduate degree from Heriot-Watt University and a doctorate from The University of Edinburgh.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
03/07/2023 11 600 ( 0.02% ) 3 M $ 29/02/2024
15/02/2024 719 126 ( 1.90% ) 2 M $ 29/02/2024

Posizioni attive di Martin MacKay

SocietàPosizioneInizio
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director/Board Member 05/07/2017
NOVO NORDISK A/S Director/Board Member 01/03/2018
RALLYBIO CORPORATION Founder 01/01/2018
Director/Board Member -
Chief Executive Officer -
Chief Executive Officer 01/01/2018
Chief Executive Officer 22/12/2010
Tutte le posizioni attive di Martin MacKay

Precedenti posizioni note di Martin MacKay

SocietàPosizioneFine
501 ACQU Director/Board Member 22/04/2022
ALEXION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/06/2017
░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Martin MacKay

Formazione di Martin MacKay

The University of Edinburgh Doctorate Degree
Heriot-Watt University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Martin MacKay

Relazioni

99

Relazioni di 1° grado

28

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

VERISIGN. INC.

Technology Services

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Commercial Services

NOVO NORDISK A/S

Health Technology

Aziende private21

Health Technology

Health Technology

Technology Services

Commercial Services

Communications

Process Industries

Technology Services

Finance

Health Technology

Commercial Services

Commercial Services

Technology Services

Commercial Services

Technology Services

Commercial Services

Ciba-Geigy Pharmaceuticals

Beecham Pharmaceuticals (UK)

Commercial Services

Health Services

Finance

Rallybio Corp.

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Martin MacKay